Cancer Pathogenesis and Therapy, 2026 Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study Ran L., Feng J., Chen J. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Archives of Gerontology and Geriatrics, 2026 Hepatic dysfunction and long-term risk of neurodegenerative diseases: A UK Biobank-based analysis Su W., Duan Q., He S. et al. Olink Explore 3072/384NeurologyHepatologyPathophysiologyPlasma | | | | |
Diabetic Medicine, 2026 A multi‐omics risk score enables early and personalized screening for type 2 diabetes: A population‐based cohort study Bu F., Fang C., Zheng X. et al. Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma | | | | |
eBioMedicine, 2026 Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap Stinson S., Shadrin A., Rahman Z. et al. Olink Explore 3072/384Metabolic DiseasesNeurologyPathophysiologyPlasma | | | | |
Lipids in Health and Disease, 2026 Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study Kim S., Jun H., Jo G. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2026 Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab Sato Y., Kodama T., Maesaka K. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
Journal of the American Society of Nephrology, 2026 RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis Ye L., Jiang Z., Wu Y. et al. Olink Explore 3072/384NephrologyPathophysiologyPlasma | | | | |
ESC Heart Failure, 2026 Plasma protein profiles in different heart failure phenotypes Lind L., Delgado-Velandia M. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Journal of Periodontal Research, 2026 Proteomic Characterization of Grade
II
Furcation Defects: A Discovery‐Phase Study Chatzopoulos G., Sakellari D., Kaklamanos E. et al. RevealOral DiseasesPatient StratificationGingival Crevicular Fluid | | | | |
Hypertension, 2026 Integrative Proteomic Profiling of Blood Pressure and Hypertension Aggarwal M., Joehanes R., Huan T. et al. Olink Explore 3072/384Olink Explore HTCVDPathophysiologyPlasma | | | | |
Translational Psychiatry, 2026 Astrocyte-related proteins mediate the association of YWHAG with Alzheimer’s pathology and enhance its diagnostic value Zhang Z., Huang P., Yang Y. et al. Olink Explore 3072/384NeurologyPatient StratificationSerum | | | | |
Lipids in Health and Disease, 2026 Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans Larsson A., Eriksson L., Eriksson M. Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma | | | | |
Journal of Investigative Dermatology, 2026 Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls Sacknovitz Y., Zhou M., Kent J. et al. Olink Target 96OncologyPatient StratificationSerum | | | | |
Clinical Rheumatology, 2026 Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma Wang H., Yan H., Yang M. et al. Olink Target 96OncologyImmunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Cardiovascular Research, 2026 miR-146a-5p mediates atherogenic signalling from immune to vascular cells Climent M., Zani S., Salvarani N. et al. Olink Target 96 MouseT48 MouseCVDPathophysiologyMouse Serum | | | | |
HemaSphere, 2026 Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients Diorio C., Myers R., Li Y. et al. Olink Target 96OncologyImmunotherapyPatient StratificationSerum | | | | |
Metabolism, 2026 When the proteome meets the metabolome observational and Mendelian randomization analyses Zheng R., Delgado-Velandia M., Ärnlöv J. et al. Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
CNS Neuroscience & Therapeutics, 2026 Olink Proteomics Reveals
CCL2
Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via
CCR2
/
NF
‐
κB
‐Mediated Blood–Brain Barrier Disruption Huang R., Gao L., Dai Y. et al. Olink Target 96Neurovascular DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Open Forum Infectious Diseases, 2026 Proteomic Profile After Intervention With Eplerenone Among Persons With HIV Murthy A., Kolossváry M., Walpert A. et al. Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma | | | | |
Pulmonology, 2026 Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study He L., Liu C., Zhao H. et al. Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma | | | | |